Produktinformation
- 1,6-Dioxaspiro[4.5]decane, maduramicin α deriv.
- (29S)-9,13:17,20:21,24-Trianhydro-2,4,8,10,12,14,15,18,19,23,26,27,28,30-tetradecadeoxy-4,8,10,26,28-pentamethyl-16,20-di-C-methyl-5,6-di-O-methyl-22-[(2,6-dideoxy-3,4-di-O-methyl-β-L-arabinopyranosyl)oxy]-L-glycero-L-allo-α-D-allo-L-xylo-α-L-gluco-3,13,29-triacontotriulo-13,16-furanose-3,7:29,25-dipyranosonic acid
- Antibiotic X 14868A
- Maduramicin α
Maduramicin is a quillaja saponaria-derived natural product that exhibits potent antibacterial activity with a novel mechanism of action. It inhibits the synthesis of bacterial DNA and RNA, which leads to cell death by inhibiting protein synthesis. Maduramicin has been shown to be active against drug-resistant Staphylococcus aureus and Mycobacterium tuberculosis. Maduramicin also induces caspase-independent cell death in human cells, but not in murine cells. This effect is due to its ability to inhibit mitochondrial membrane potential and energy metabolism.
3-Desacetylcefotaxime potassium (3DCTKP) is an antibacterial agent that belongs to the group of β-lactam antibiotics. It is a prodrug that is hydrolyzed in vivo to cefotaxime, its active form. 3DCTKP has antagonistic effects against clostridium and can be used for
